Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

GB virus C/hepatitis G virus.

R Halasz1, O Weiland, M Sällberg

  • 1Division of Clinical Virology, Karolinska Institutet, Huddinge University Hospital, Sweden.

Scandinavian Journal of Infectious Diseases
|August 30, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ATMP development and pre-GMP environment in academia: a safety net for early cell and gene therapy development and manufacturing.

Immuno-oncology technology·2022
Same author

Designing a therapeutic hepatitis B vaccine to circumvent immune tolerance.

Human vaccines & immunotherapeutics·2019
Same author

Introduction of the second-generation direct-acting antivirals (DAAs) in chronic hepatitis C: a register-based study in Sweden.

European journal of clinical pharmacology·2018
Same author

Cirrhosis, high age and high body mass index are risk factors for persisting advanced fibrosis after sustained virological response in chronic hepatitis C.

Journal of viral hepatitis·2018
Same author

Activated Cellular Immunity in Chronic Hepatitis C.

Hematology (Amsterdam, Netherlands)·2016
Same author

Incidence and outcome of Staphylococcus aureus endocarditis--a 10-year single-centre northern European experience.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2015
Same journal

Fas-Ligand Mediated Apoptosis in Severe Sepsis and Shock.

Scandinavian journal of infectious diseases·2017
Same journal

Lipopolysaccharide-inducible Gene Expression Profile in Human Monocytes.

Scandinavian journal of infectious diseases·2017
Same journal

Fatal varicella pneumonia.

Scandinavian journal of infectious diseases·2015
Same journal

Wissler's Syndrome Associated with Parainfluenza 2 Infection.

Scandinavian journal of infectious diseases·2015
Same journal

Contamination of smears with "sergentella spiroides".

Scandinavian journal of infectious diseases·2015
Same journal

Recrudescent typhus: fluctuations in titers of complement-fixing and microagglutinating antibodies to rickettsia prowazeki in persons with a history of epidemic typhus.

Scandinavian journal of infectious diseases·2015
See all related articles

GB virus C (GBV-C), also known as hepatitis G virus (HGV), is a flavivirus with widespread prevalence. Current evidence suggests GBV-C/HGV is not a primary cause of liver disease.

Area of Science:

  • Virology
  • Hepatology

Background:

  • GB virus C (GBV-C), or hepatitis G virus (HGV), is an enveloped RNA virus in the Flaviviridae family.
  • Transmission routes include blood products, IV drug use, mother-to-child, sexual contact, and close social contact.
  • High viremia prevalence is reported globally, particularly in South America and Africa.

Purpose of the Study:

  • To evaluate the role of GBV-C/HGV as a causative agent of non-A-non-E hepatitis.
  • To synthesize current data on GBV-C/HGV's association with liver disease.

Main Methods:

  • Review of existing epidemiological and clinical data on GBV-C/HGV.
  • Analysis of studies investigating GBV-C/HGV infection and liver pathology.

Main Results:

Related Experiment Videos

  • GBV-C/HGV has a significant global prevalence, with viremia detected in 1-33% of populations studied.
  • Contradictory findings exist regarding its etiological role in hepatitis.
  • Recent data indicate hepatocyte infection and replication, but its clinical significance remains debated.

    • Conclusions:

    • Despite evidence of hepatocyte tropism, GBV-C/HGV is unlikely to be a major cause of non-A-non-E hepatitis.
    • Further research is needed to clarify the clinical impact of GBV-C/HGV infection.